Celltech AB
ABActiveAdvertising protectionOrg 5562398502Allmänningsvägen 81, 176 76 JärfällaWholesale of other machinery and equipment· NACE 4664Est. 1984 · 42 years old20-49 employees
Loading company…
Overview
Celltech AB is a Swedish AB based in Järfälla, operating in the Wholesale of other machinery and equipment sector. Incorporated in 1984, the company reported revenue of SEK 0 in its latest annual filing.
Revenue 2025
0M SEK
EBITDA margin
—
Net profit 2025
0M SEK
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
96.6 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
5.6×
StrongAmong the 30% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
0.0 %
WeakAmong the 40% lowest rated companies in the industry
20212025
EBITDA — year on year
SEKKey figures
Annual report 2025| Revenue | 0M SEK | — |
| EBITDA | 0M SEK | — |
| Net profit | 0M SEK | — |
| Total assets | 4.3M SEK | +612% |
| Equity | 4.1M SEK | +588% |
| Employees | — | — |
Company information
Legal name
Celltech AB
Org number
5562398502
Legal form
Aktiebolag
NACE code
Founded
31 January 1984 · 42 years
Share capital
SEK 355,000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva handel, marknadsföring och konsult- verksamhet inom batteri- och elektronikkomponent området samt idka därmed förenlig verksamhet.
(no translation available)
Contact
Address
Allmänningsvägen 81, 176 76 Järfälla
Phone
+4684457870
Email
info@celltech.se
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Celltech AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a break-even result.
At the end of 2025, equity financed 96.6% of the balance sheet, and current assets covered short-term debt 5.6 times.
Financials
Revenue
SEKEBITDA
SEKIncome statement
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | — | — |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
Balance sheet
SEK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 4,259 | 598 | 598 | 439 | 6,980 |
| Equity | 4,114 | 598 | 598 | 439 | 6,980 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 145 | 0 | 0 | 0 | 0 |
| Total debt | 145 | — | — | — | — |
Financial ratios
5-year trendEBITDA margin
0.0 %
20212025
Equity ratio
96.6 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Return on equity
0.0 %
WeakAmong the 40% lowest rated companies in the industry
20212025
Net profit margin
0.0 %
20212025
Asset turnover
0.00×
Very weakAmong the 10% lowest rated companies in the industry
20212025
Debt / equity
0.04×
Very strongAmong the 10% highest rated companies in the industry
20212025
Sector performance
19 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 40% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Average
Around the average of companies in the same industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioStrong
Among the 30% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 20% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioVery weak
Among the 10% lowest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery strong
Among the 10% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery weak
Among the 20% lowest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery strong
Among the 10% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 10% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery strong
Among the 10% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery strong
Among the 20% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtWeak
Among the 40% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
Interest rate on debtVery strong
Among the 10% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginWeak
Among the 40% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
EBITDA to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Efficiency & development
Asset turnoverVery weak
Among the 10% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalStrong
Among the 40% highest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery strong
Among the 10% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
One-year change in debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The size of this year's increase or decrease in the company's debt.
Annual reports & filings
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ZM Chief Auditor | Chief Auditor | 2023 |
PE Chief Executive Officer | Chief Executive Officer | 2020 |
Former (5)
TS Chief Auditor | Chief Auditor | 2020 – 2021 |
PC Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
EJ Chief Auditor | Chief Auditor | 2021 – 2022 |
AS Chief Auditor | Chief Auditor | 2022 – 2023 |
AH Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
PL Board of Directors | Board of Directors | 2020 |
PE Board of Directors | Board of Directors | 2022 |
KK Chairman | Chairman | 2025 |
Former (4)
TK Board of Directors | Board of Directors | 2022 – 2024 |
PC Chairman | Chairman | 2020 – 2024 |
PE Board of Directors | Board of Directors | 2020 – 2022 |
CO Chairman | Chairman | 2024 – 2025 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Related companies
Company hierarchy
Addtech AB
Celltech AB Board network connections
Board members of Celltech AB also hold positions in 294 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zlatko Mehinagic | Chief Auditor | 124 companiesMany roles |
| Tatijana Strömstedt | Chief Auditor | 104 companiesMany roles |
| Alexandra Sofia Sikström | Chief Auditor | 40 companiesMany roles |
| Per Lennart Lundblad | Board of Directors | 11 companiesMany roles |
| Christian Olof Gunnar Goding | Chairman | 6 companiesMany roles |
| Peter Carl Mikael Andersson | Chief Executive Officer | 3 companies |
| Patrik Elving | Chief Executive Officer | 2 companies |
| Kim Kristian Nikitin | Chairman | 2 companies |
| Timo Kanerva | Board of Directors | 1 company |
| Per Erik Tomas Pehrsson | Board of Directors | 1 company |
Frequently asked questions
What is the Org number of Celltech AB?
Celltech AB is registered with Bolagsverket / SCB under Org 5562398502.
Who is the CEO of Celltech AB?
Patrik Elving is the CEO of Celltech AB, in role since 2020.
Who is the chairman of Celltech AB?
Kim Kristian Nikitin chairs the board of Celltech AB, in role since 2025.
Where is Celltech AB headquartered?
Celltech AB's registered address is Allmänningsvägen 81.